AMANDA APPLING: Open Payments
NPI 1386938611 · CUMMING, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,933 in 129 payments from 21 companies in 2025. Trend: 2023 $4,190 · 2024 $4,914 · 2025 $2,933
Food & beverage: $2,933
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $622 |
| UCB, Inc. | 19 | $416 |
| Amgen Inc. | 18 | $383 |
| Janssen Biotech, Inc. | 11 | $259 |
| Mallinckrodt Hospital Products Inc. | 8 | $216 |
| Novartis Pharmaceuticals Corporation | 10 | $174 |
| AstraZeneca Pharmaceuticals LP | 5 | $141 |
| GlaxoSmithKline, LLC. | 6 | $128 |
| ANI Pharmaceuticals, Inc. | 4 | $123 |
| SOBI, INC | 4 | $97 |
Products named: RINVOQ, Bimzelx, TREMFYA, ACTHAR, COSENTYX, KRYSTEXXA, SKYRIZI, SAPHNELO.
Industry payments across GA — which companies pay providers there.
